Journal Scans
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA)
Radiotherapy Management of Testicular Seminoma Is Challenged
T Tandstad, R Smaaland, A Solberg, RM Bremnes, CW Langberg, A Laurell, UK Stierner, O Ståhl, EK Cavallin-Ståhl, OH Klepp, O Dahl, G Cohn-Cedermark
20110004
2011 Jan 4
J Clin Oncol
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA)
J Clin Oncol. 2011 Jan 4;[Epub Ahead of Print], T Tandstad, R Smaaland, A Solberg, RM Bremnes, CW Langberg, A Laurell, UK Stierner, O Ståhl, EK Cavallin-Ståhl, OH Klepp, O Dahl, G Cohn-Cedermark
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Testicular seminoma has excellent cure rates in response to chemotherapy and radiation therapy, even when metastatic. The Swedish and Norwegian Testicular Cancer Project (SWENOTECA) provides programs for management of testicular cancer. SWENOTECA V was a standardized protocol for the treatment of patients with seminoma. The goal of this program, which was activated in January 2000, was to improve treatment results and reduce the use of radiotherapy. A total of 1384 patients were included in a prospective...
